China Innovation Investment Limited (1217.HK)

China Innovation Investment Limited (1217.HK) — VMCI valuation read

1217.HK screens at VMCI 72/100, a 22-point gap above the Financial Services sector median (50). For a mid-cap China Innovation Investment Limited share, that placement says the multi-pillar composite is cheaper or higher quality than the typical peer on a like-for-like basis.

1217.HK has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: 1217.HK trades at 22.0x earnings, 22% above the Financial Services median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Financial Services group. Quality: ROIC of 12.0% sits 2.0pp above the Financial Services median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 1.1x leaves covenant headroom, which sets the rate-cycle exposure for China Innovation Investment Limited.

1217.HK fell 1.6% over the trailing 7 days, with a -13.7% read on a 30-day basis.